CompletedPhase 4ketamine

Etomidate Versus Ketamine for Emergency Endotracheal Intubation: a Prospective Randomized Clinical Trial

Sponsored by University of Texas Southwestern Medical Center

NCT ID
NCT02643381
Target Enrollment
801 participants
Start Date
2016-06-06
Est. Completion
2020-12-01

About This Study

Patients who are having problems breathing sometimes require placement of a breathing tube in their mouth and windpipe. The purpose of this breathing tube is to save the patient's life. It is common to give the patient a medication to sedate him or her before the breathing tube is placed. For patients who are gravely ill two medications are commonly used: etomidate or ketamine. Both medications have risks and benefits. Researchers at UT-Southwestern Medical Center and Parkland Memorial Hospital would like to do a study to figure out which one is better for our patients.

Conditions Studied

Cardiopulmonary ArrestRespiratory Arrest

Interventions

  • Etomidate
  • Ketamine
  • Emergency Endotracheal Intubation
  • Mechanical Ventilation

Eligibility

Age:18 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Adult patient (male or female) requiring emergency endotracheal intubation.

Exclusion Criteria:

* Children (\<18 years old).
* Women who are known to be pregnant.
* Any patient who has been previously randomized in the EvK Trial.
* Patients who require endotracheal intubation without sedative medication. For example, patients in full cardiac arrest.
* Patients with a known allergy to ketamine or etomidate.
* Any individual wearing a MedAlert bracelet indicating that he/she has formally opted out of the EvK Trial.

Study Locations (1)

Parkland Hospital
Dallas, Texas, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source